Ran Taube

2.9k total citations
52 papers, 2.0k citations indexed

About

Ran Taube is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Ran Taube has authored 52 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Virology, 22 papers in Molecular Biology and 20 papers in Infectious Diseases. Recurrent topics in Ran Taube's work include HIV Research and Treatment (26 papers), RNA Research and Splicing (13 papers) and HIV/AIDS drug development and treatment (12 papers). Ran Taube is often cited by papers focused on HIV Research and Treatment (26 papers), RNA Research and Splicing (13 papers) and HIV/AIDS drug development and treatment (12 papers). Ran Taube collaborates with scholars based in Israel, United States and Germany. Ran Taube's co-authors include Koh Fujinaga, B. Matija Peterlin, Dan Irwin, David H. Price, Alona Kuzmina, Sheng‐Hao Chao, Edward A. Sausville, Adrian M. Senderowicz, Ye-Hong Huang and Thomas P. Cujec and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Ran Taube

51 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Taube Israel 21 1.2k 767 532 344 277 52 2.0k
Massimo Mallardo Italy 28 983 0.8× 387 0.5× 185 0.3× 494 1.4× 344 1.2× 59 2.2k
Anne Randolph United States 10 588 0.5× 487 0.6× 253 0.5× 280 0.8× 60 0.2× 11 1.5k
Zheng Ge China 27 1.5k 1.3× 218 0.3× 178 0.3× 183 0.5× 346 1.2× 134 2.4k
B I Gerwin United States 22 981 0.8× 171 0.2× 111 0.2× 283 0.8× 789 2.8× 33 2.2k
Jaromir Vlach United States 20 1.0k 0.9× 161 0.2× 184 0.3× 812 2.4× 871 3.1× 28 2.2k
Shunbin Ning United States 30 932 0.8× 162 0.2× 271 0.5× 1.2k 3.4× 729 2.6× 88 2.6k
René Daniel United States 23 1.2k 1.0× 473 0.6× 323 0.6× 180 0.5× 341 1.2× 49 1.8k
Joachim Lupberger France 19 484 0.4× 65 0.1× 104 0.2× 165 0.5× 136 0.5× 37 1.4k
Stephen H. Thorne United States 31 1.0k 0.9× 68 0.1× 189 0.4× 766 2.2× 1.2k 4.2× 56 2.6k

Countries citing papers authored by Ran Taube

Since Specialization
Citations

This map shows the geographic impact of Ran Taube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Taube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Taube more than expected).

Fields of papers citing papers by Ran Taube

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Taube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Taube. The network helps show where Ran Taube may publish in the future.

Co-authorship network of co-authors of Ran Taube

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Taube. A scholar is included among the top collaborators of Ran Taube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Taube. Ran Taube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuzmina, Alona, et al.. (2025). Engineering non-pathogenic bacteria for auto-transporter-driven secretion of functional interferon. Gut Microbes. 17(1). 2474146–2474146.
2.
Taube, Ran, et al.. (2024). Role of long noncoding RNA in regulating HIV infection—a comprehensive review. mBio. 15(2). e0192523–e0192523. 3 indexed citations
3.
Kuzmina, Alona, M. Hasanuzzaman, Koh Fujinaga, et al.. (2024). Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression. PLoS Pathogens. 20(4). e1012172–e1012172. 2 indexed citations
4.
5.
Kuzmina, Alona, Ayelet Keren‐Naus, Yael Raviv, et al.. (2021). SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera. Cell Host & Microbe. 29(4). 522–528.e2. 118 indexed citations
6.
Kuzmina, Alona, Aner Ottolenghi, Benyamin Rosental, et al.. (2021). SARS CoV-2 Delta variant exhibits enhanced infectivity and a minor decrease in neutralization sensitivity to convalescent or post-vaccination sera. iScience. 24(12). 103467–103467. 20 indexed citations
7.
Taube, Ran, et al.. (2021). Amyloid β structural polymorphism, associated toxicity and therapeutic strategies. Cellular and Molecular Life Sciences. 78(23). 7185–7198. 13 indexed citations
8.
Kuzmina, Alona, et al.. (2020). Genome-wide CRISPR knockout screen identifies ZNF304 as a silencer of HIV transcription that promotes viral latency. PLoS Pathogens. 16(9). e1008834–e1008834. 44 indexed citations
9.
Kuzmina, Alona, et al.. (2019). Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation. Retrovirology. 16(1). 16–16. 16 indexed citations
10.
Mizrahi, Solly, Yonat Shemer Avni, Ran Taube, et al.. (2018). Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells. Cellular Reprogramming. 20(1). 17–26. 9 indexed citations
11.
Banerjee, Victor, et al.. (2017). A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity. Journal of Biological Chemistry. 292(38). 15777–15788. 12 indexed citations
12.
Kuzmina, Alona, et al.. (2015). Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes. PLoS ONE. 10(12). e0144043–e0144043. 10 indexed citations
13.
Kuzmina, Alona, Uzi Hadad, Koh Fujinaga, & Ran Taube. (2012). Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1. Virology. 426(2). 152–161. 2 indexed citations
14.
Cohen, Idan, et al.. (2012). ZNF750 Is Expressed in Differentiated Keratinocytes and Regulates Epidermal Late Differentiation Genes. PLoS ONE. 7(8). e42628–e42628. 38 indexed citations
15.
Kuzmina, Alona, et al.. (2012). Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin. Virology. 428(2). 98–111. 43 indexed citations
16.
Diaz‐Griffero, Felipe, Ran Taube, Stefan M. Muehlbauer, & Jürgen Brojatsch. (2008). Efficient production of HIV-1 viral-like particles in mouse cells. Biochemical and Biophysical Research Communications. 368(3). 463–469. 8 indexed citations
17.
Taube, Ran, Quan Zhu, Xu Chen, et al.. (2008). Lentivirus Display: Stable Expression of Human Antibodies on the Surface of Human Cells and Virus Particles. PLoS ONE. 3(9). e3181–e3181. 24 indexed citations
18.
Fujinaga, Koh, Ran Taube, Thomas P. Cujec, et al.. (1999). Interactions between Tat and TAR and Human Immunodeficiency Virus Replication Are Facilitated by Human Cyclin T1 but Not Cyclins T2a or T2b. Virology. 255(1). 182–189. 71 indexed citations
19.
Taube, Ran, et al.. (1998). DNA synthesis exhibited by the reverse transcriptase of mouse mammary tumor virus : Processivity and fidelity of misinsertion and mispair extension. European Journal of Biochemistry. 258(3). 1032–1039. 14 indexed citations
20.
Rubinek, Tamar, Mary Bakhanashvili, Ran Taube, Orna Avidan, & Amnon Hizi. (1997). The Fidelity of 3′ Misinsertion and Mispair Extension During DNA Synthesis Exhibited by two Drug‐Resistant Mutants of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 with Leu74→Val and Glu89→Gly. European Journal of Biochemistry. 247(1). 238–247. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Mallardo Breakdown of academic impact, for papers by Anne Randolph Breakdown of academic impact, for papers by Zheng Ge Breakdown of academic impact, for papers by B I Gerwin Breakdown of academic impact, for papers by Jaromir Vlach Breakdown of academic impact, for papers by Shunbin Ning Breakdown of academic impact, for papers by René Daniel Breakdown of academic impact, for papers by Joachim Lupberger Breakdown of academic impact, for papers by Stephen H. Thorne
Rankless by CCL
2026